Goto

Collaborating Authors

 apella announce


Apella Announces $21 Million Series A Funding to Digitize the Operating Room

#artificialintelligence

"Apella believes that every patient deserves the best possible outcome from surgery," commented David Schummers, co-founder and CEO of Apella. "Our technology is aimed at helping each member of the surgical team to do their best job." Apella's initial products include sensors installed in the operating room and harness a variety of artificial intelligence approaches to collect and analyze new data about surgery. This data contributes to applications targeted at improving hospital operations, surgical quality, staff training and real-time decision making with the overall goal of improving the quality of surgical care. "At Apella, we know that you can't improve what you can't measure," continued Schummers.


Apella Announces $21 Million Series A Funding to Digitize the Operating Room

#artificialintelligence

The Company's technology harnesses artificial intelligence to create a systematic method for process improvement and quality control in surgery.